Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Leukemia, Megakaryoblastic, Acute × Pharmacogenomic Testing × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Unspecified Adult Solid Tumor, Protocol Specific 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Squamous Cell Carcinoma of Head and Neck 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasms, Plasma Cell 1 Neoplasm Metastasis 1 Myeloproliferative Disorders 1 Myelodysplastic-Myeloproliferative Diseases 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Melanoma 1 Malignant Tumor of Ill-defined Site 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, Non-Hodgkin 1 Lymphoma, Large-Cell, Immunoblastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lymphoma, Extranodal NK-T-Cell 1 Lymphoma, B-Cell, Marginal Zone 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1 Leukemia, Myeloid, Acute 1

Interventions

Cytarabine 19 fludarabine phosphate 8 Busulfan 7 Mitoxantrone 6 Idarubicin 6 Peripheral Blood Stem Cell Transplantation 5 Whole-Body Irradiation 4 Vorinostat 4 Methotrexate 4 Gemtuzumab 4 Filgrastim 4 Etoposide 4 Daunorubicin 4 Cyclosporine 4 Clofarabine 4 Antilymphocyte Serum 4 tipifarnib 3 alvocidib 3 Tacrolimus 3 Mycophenolic Acid 3 Flow Cytometry 3 Decitabine 3 Cyclophosphamide 3 Azacitidine 3 aldesleukin 2 Pravastatin 2 Observation 2 In Situ Hybridization, Fluorescence 2 Cytogenetic Analysis 2 Bortezomib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡